SCHEMBL27735638

SCHEMBL27735638

CCCC(=O)On1nc2ncccc2c1I

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 1/20 0.40
▸ GSK3B P49841 1/20 0.40
▸ MAOB P27338 2/20 0.38
▸ ELANE P08246 2/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ NPC1 O15118 1/20 0.36
▸ BRD4 O60885 1/20 0.36
▸ MITF O75030 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36
▸ FAAH O00519 9/20 0.35
▸ ASAH1 Q13510 1/20 0.34
▸ KDM4A O75164 1/20 0.34
▸ KDM4C Q9H3R0 1/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ DAGLA Q9Y4D2 5/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27714803 0.85 MAOB (0.39) MAOBELANEKDM4EBRD4MEN1
SCHEMBL27735688 0.78 ELANE (0.41) GSK3AGSK3BELANEKDM4EL3MBTL1
SCHEMBL27735636 0.75 L3MBTL1 (0.46) GSK3AGSK3BMAOBELANEKDM4E
SCHEMBL1639229 0.74 GAA (0.47) MAOBKDM4EL3MBTL1MEN1KMT2A
SCHEMBL27714808 0.71 ELANE (0.40) GSK3AGSK3BELANEKDM4EL3MBTL1
SCHEMBL12726405 0.70 MAOB (0.39) GSK3AGSK3BMAOBELANEMEN1
SCHEMBL1637819 0.69 ALOX15 (0.42) KDM4E
SCHEMBL28372779 0.64 HPSE (0.40) ELANEKDM4EKMT2A
SCHEMBL1638885 0.63 MEN1 (0.47) MAOBL3MBTL1MEN1KMT2A
SCHEMBL27746408 0.63 ALDH1A1 (0.36) ELANEKDM4EL3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101242839-B Azaindazole compounds and methods of use CHEMOCENTRYX INC 2012-11-07 — — CN disclosed
CN-101242839-A Azaindazole compounds and methods of use CHEMOCENTRYX INC (US) 2008-08-13 — — CN disclosed
Send feedback